(Q43628209)

25 November 2017

title

Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expression (English)

1 reference

25 November 2017

1 reference

10

Andreas von Deimling

1 reference

25 November 2017

Virginie Desestret

1

1 reference

25 November 2017

Pietro Ciccarino

2

1 reference

25 November 2017

François Ducray

3

1 reference

25 November 2017

Emmanuelle Crinière

4

1 reference

25 November 2017

Blandine Boisselier

5

1 reference

25 November 2017

Marianne Labussière

6

1 reference

25 November 2017

Marc Polivka

7

1 reference

25 November 2017

Ahmed Idbaih

8

1 reference

25 November 2017

Gentian Kaloshi

9

1 reference

25 November 2017

Khe Hoang-Xuan

11

1 reference

25 November 2017

Jean-Yves Delattre

12

1 reference

25 November 2017

Karima Mokhtari

13

1 reference

25 November 2017

Marc Sanson

14

1 reference

25 November 2017

publication date

24 April 2011

1 reference

Journal of Neuro-Oncology

25 November 2017

published in

1 reference

25 November 2017

volume

105

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

219-224

1 reference

Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Initial chemotherapy in gliomatosis cerebri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

alpha-Internexin expression identifies 1p19q codeleted gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0587-4

10.1007/S11060-011-0587-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

1040924422

0 references

1 reference